MENU_IR_QA

Kontaktinfo vedr. Q&A og andel digital IR:

Going into dialogue with your Equity Story

The World of Finance is global and your Company's Equity Story can be global too

Focused dialogue tool directed to the Retail Investor
Easy to use by both listed companies and our site users
Increased visibility before, during and after

"We are a relatively unkown company with well-known products such as the Danske Bank Mobile Banking, and therefore Q&A Retail is an obvious way for us to increase investor's awareness of ourselves, which is be beneficial to the liquidity of our stock. We were very pleased with our first Q&A Retail session and we will certainly consider repeating this success. Because Q&A Retail at the same time signals smartness in terms of our own technlology." Jørn Larsen, CEO Trifork

Q&A Retail

ProInvestors chat, Q&A Retail is a unique opportunity for online live dialogue with Nordic Retail Investors. ProInvestor facilitates chat and serves as moderator of the questions. Everything you need to do is to log in via ProInvestors website and answer questions from our interested ProInvestor users - live and straightforward. Q&A Retail creates increased visibility before,during and after chatting with advertising in the newsletter and on proinvestor.com and subsequent transcript of the session, which can be uploaded to your own site or transferred to other digital Social Media.

History

Date	Company	Topic

11.5.2016		Session with CEO, Prof. Jan Van de Winkel, Q1 Genmab See transcript
13.11.2015		Session with VP Hanne Leth Hillmann, Q3 Zealand Pharma See transcript
11.11.2015		Session with CEO, Prof. Jan Van de Winkel, Q3 Genmab See transcript
12.08.2015		Session with CEO, Prof. Jan Van de Winkel, Q2 Genmab See transcript
13.05.2015		Session with CEO, Prof. Jan Van de Winkel, Q1 Genmab See transcript


04.03.2015		Session with CEO, Prof. Jan Van de Winkel, Q4 Genmab See transcript

06.11.2014		Session with CEO, Prof. Jan Van de Winkel, Q3 Genmab See transcript

14.08.2014		Session with CEO, Prof. Jan Van de Winkel, Q2 Genmab See transcript

08.05.2014		Session with CEO, Prof. Jan Van de Winkel, Q1 Genmab See transcript

15.08.2013		Session with CEO, Prof. Jan Van de Winkel, Q2 Genmab See transcript

08.05.2013		Session with CEO, Prof. Jan Van de Winkel, Q3 Genmab See transcript

08.11.2012		Session with CEO, Prof. Jan Van de Winkel, Q3 Genmab See transcript
16.08.2012		Session with CEO, Prof. Jan Van de Winkel, Q2 Genmab See transcript

16.05.2012		Session with CEO, Prof. Jan Van de Winkel, Q1 Genmab See transcript

08.03.2012		Session with CEO, Prof. Jan Van de Winkel, Q4 Genmab See transcript

04.11.2011		Session with CEO, Prof. Jan Van de Winkel, Q3 Genmab See transcript

08.08.2011		Session with CEO, Prof. Jan Van de Winkel, Q2 Genmab See transcript

Booking

Contact us at [email protected]